The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
Weight-loss drugs like Ozempic and Zepbound would be covered by Medicare and Medicaid, giving access to millions of ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
WASHINGTON — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound ...